138 related articles for article (PubMed ID: 23036585)
21. Cyclin-dependent kinase 5 is associated with risk for Alzheimer's disease in a Dutch population-based study.
Arias-Vásquez A; Aulchenko YS; Isaacs A; van Oosterhout A; Sleegers K; Hofman A; van Broeckhoven C; Oostra BA; Breteler M; van Duijn CM
J Neurol; 2008 May; 255(5):655-62. PubMed ID: 18350355
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
[TBL] [Abstract][Full Text] [Related]
23. Lower Prevalence of Alzheimer's Disease among Tibetans: Association with Religious and Genetic Factors.
Huang F; Shang Y; Luo Y; Wu P; Huang X; Tan X; Lu X; Zhen L; Hu X
J Alzheimers Dis; 2016; 50(3):659-67. PubMed ID: 26757186
[TBL] [Abstract][Full Text] [Related]
24. Association of PICALM with Cognitive Impairment in Parkinson's Disease.
Periñán MT; Macías-García D; Labrador-Espinosa MÁ; Jesús S; Buiza-Rueda D; Adarmes-Gómez AD; Muñoz-Delgado L; Gómez-Garre P; Mir P
Mov Disord; 2021 Jan; 36(1):118-123. PubMed ID: 32914893
[TBL] [Abstract][Full Text] [Related]
25. Genetic Association between Alzheimer's Disease Risk Variant of the PICALM Gene and Auditory Event-Related Potentials in Aging.
Ponomareva NV; Andreeva TV; Protasova MA; Filippova YV; Kolesnikova EP; Fokin VF; Illarioshkin SN; Rogaev EI
Biochemistry (Mosc); 2018 Sep; 83(9):1075-1082. PubMed ID: 30472946
[TBL] [Abstract][Full Text] [Related]
26. CR1, ABCA7, and APOE genes affect the features of cognitive impairment in Alzheimer's disease.
Chung SJ; Kim MJ; Kim YJ; Kim J; You S; Jang EH; Kim SY; Lee JH
J Neurol Sci; 2014 Apr; 339(1-2):91-6. PubMed ID: 24530172
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide analysis of genetic predisposition to Alzheimer's disease and related sex disparities.
Nazarian A; Yashin AI; Kulminski AM
Alzheimers Res Ther; 2019 Jan; 11(1):5. PubMed ID: 30636644
[TBL] [Abstract][Full Text] [Related]
28. The nitric oxide synthase 3 G894T polymorphism associated with Alzheimer's disease risk: a meta-analysis.
Liu S; Zeng F; Wang C; Chen Z; Zhao B; Li K
Sci Rep; 2015 Sep; 5():13598. PubMed ID: 26337484
[TBL] [Abstract][Full Text] [Related]
29. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
[TBL] [Abstract][Full Text] [Related]
30. LACK OF ASSOCIATIONS BETWEEN CLU AND PICALM GENE POLYMORPHISMS AND ALZHEIMER'S DISEASE IN A TURKISH POPULATION.
Sen A; Arslan M; Erdal ME; Ay OI; Yilmaz SG; Kurt E; Arpaci B
Ideggyogy Sz; 2015 Mar; 68(3-4):113-20. PubMed ID: 26434199
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease.
Ozturk A; DeKosky ST; Kamboh MI
Neurobiol Aging; 2006 Oct; 27(10):1440-4. PubMed ID: 16223550
[TBL] [Abstract][Full Text] [Related]
32. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ
Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559
[TBL] [Abstract][Full Text] [Related]
33. Alzheimer's disease genes and cognition in the nondemented general population.
Verhaaren BF; Vernooij MW; Koudstaal PJ; Uitterlinden AG; van Duijn CM; Hofman A; Breteler MM; Ikram MA
Biol Psychiatry; 2013 Mar; 73(5):429-34. PubMed ID: 22592056
[TBL] [Abstract][Full Text] [Related]
34. Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease.
Morgen K; Ramirez A; Frölich L; Tost H; Plichta MM; Kölsch H; Rakebrandt F; Rienhoff O; Jessen F; Peters O; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Hampel H; Teipel SJ; Pantel J; Heuser I; Wiltfang J; Rüther E; Kornhuber J; Maier W; Meyer-Lindenberg A
Alzheimers Dement; 2014 Oct; 10(5 Suppl):S269-76. PubMed ID: 24613704
[TBL] [Abstract][Full Text] [Related]
35. Association of MTHFR and PICALM polymorphisms with Alzheimer's disease.
Belcavello L; Camporez D; Almeida LD; Morelato RL; Batitucci MC; de Paula F
Mol Biol Rep; 2015 Mar; 42(3):611-6. PubMed ID: 25359311
[TBL] [Abstract][Full Text] [Related]
36. rs3851179G>A in PICALM is Protective Against Alzheimer's Disease in Five Different Countries Surrounding the Mediterranean.
Masri I; Salami A; El Shamieh S; Bissar-Tadmouri N
Curr Aging Sci; 2020; 13(2):162-168. PubMed ID: 31648652
[TBL] [Abstract][Full Text] [Related]
37. No association of lipase C polymorphisms with Alzheimer's disease.
Laws SM; Eckart K; Friedrich P; Eisele T; Kurz A; Förstl H; Riemenschneider M
Neurobiol Aging; 2010 Dec; 31(12):2192-3. PubMed ID: 19155102
[TBL] [Abstract][Full Text] [Related]
38. Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.
Rodríguez-Rodríguez E; Sánchez-Juan P; Vázquez-Higuera JL; Mateo I; Pozueta A; Berciano J; Cervantes S; Alcolea D; Martínez-Lage P; Clarimón J; Lleó A; Pastor P; Combarros O
J Neural Transm (Vienna); 2013 May; 120(5):807-12. PubMed ID: 23180304
[TBL] [Abstract][Full Text] [Related]
39. A Multi-Marker Genetic Association Test Based on the Rasch Model Applied to Alzheimer's Disease.
Wang W; Mandel J; Bouaziz J; Commenges D; Nabirotchkine S; Chumakov I; Cohen D; Guedj M;
PLoS One; 2015; 10(9):e0138223. PubMed ID: 26379234
[TBL] [Abstract][Full Text] [Related]
40. Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.
Elcoroaristizabal Martín X; Fernández Martínez M; Galdos Alcelay L; Molano Salazar A; Bereincua Gandarias R; Inglés Borda S; Gómez Busto F; Uterga Valiente JM; Indakoetxea Juanbeltz B; Gómez Beldarraín MA; de Pancorbo MM
Dement Geriatr Cogn Disord; 2011; 32(5):332-41. PubMed ID: 22311091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
